|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review |
 |
Aggressive
treatment of at-risk patients should be pursued early Lipid lowering is the mainstay of treatment: it reduces clinical events and regresses plaque ACE inhibitors and CCBs are being shown to have antiatherosclerotic actions and effects on clinical events
|
